Tempus listed on the NASDAQ stock exchange, providing diagnostic data and AI tools to facilitate drug approval processes.
6 reports, 3 independent
Updated Thu 00:00
Mostly repetition
- Reports
- 6
- Developments
- 2
- Repetition
- 83%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tempus listed on the NASDAQ stock exchange, providing diagnostic data and AI tools to facilitate drug approval processes.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Tempus listed on Nasdaq, filed disclosures with the SEC, and received research reports from Jefferies Financial Group.Sub-event
Tempus IPO on NASDAQ highlights its role in AI diagnostics and drug approval.1 source
Keep exploring
The entities involved
-
Tempus
biotechnology company based in Chicago, Illinois
-
Nasdaq
American fully electronic stock exchange